University of Colorado

January 14, 2016January 14, 2016

Rights to Patent for Lung Cancer Prevention Drug Iloprost Acquired by VisionGate

Lung Cancer, News

VisionGate, a Phoenix-based company focused on the early detection of lung cancer, recently announced that it has acquired exclusive rights to the University of Colorado’s patent for Iloprost for lung cancer ... Read more

November 4, 2014November 11, 2015

$15.6 Million Investment In Parion’s Pulmonary Research Program Might Have Huge Impact In Pulmonary Diseases

COPD, News

A five-year, $15.6 million award was recently announced for supporting continued research into mucolytic agents developed by Parion Sciences and to enable Investigational New Drug (IND) applications for these molecules. The funding ... Read more

October 17, 2014November 11, 2015

Universities Receive NIH Grants to Study Parion Sciences Products for Pulmonary Diseases

COPD, News

Emerging biopharmaceutical company, Parion Sciences, announced earlier this week that several universities have just been awarded a 5-year grant worth an estimated $15.6 million from the National Institutes of health (NIH). ... Read more